Company Overview and News

1
NS / NuStar Energy L.P. 425 (Prospectus)

12h sec.gov
425 Filed by NuStar Energy L.P.
NS

1
NS / NuStar Energy L.P. 425 (Prospectus)

12h sec.gov
425 Filed by NuStar Energy L.P.
NS

1
NS / NuStar Energy L.P. 425 (Prospectus)

2018-07-13 sec.gov
425 Filed by NuStar Energy L.P. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934
NS

1
NS / NuStar Energy L.P. 425 (Prospectus)

2018-07-13 sec.gov
425 Filed by NuStar Energy L.P. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934
NS

21
Teekay Continues To Transition - What's The Timing?

2018-07-13 seekingalpha
Teekay Corporation has been one of my largest personal holdings, largely based upon their control of Teekay LNG Partners.
TOO TK D HMLP SSW GLOP.PRA GLOP.PRB GLOP GLNG AROC DLNG TGP.PRA TGP.PRB TGP GLOG KNOP DLNG.PRA GMLP DM NS HMLP.PRA

5
Quick Picks: How Trucker Shortages Will Affect Businesses From Amazon And Walmart To Tyson Foods And Union Pacific

2018-07-11 seekingalpha
There is a shortage of truck drivers and low unemployment is making them difficult to replace.
UNP NS CSX MDLZ TSN NSC WMT

5
American Midstream: Despite Yield, Buying Appears Early

2018-07-10 seekingalpha
Distribution coverage is barely there, and would not be there without general partner support. Covenant violations would have occurred without that aid.
ETP.PRC RDS.B RDS.A HES RDSB RDSA SXE NS.PRC NS.PRB ETP CAPL CVX RYDBF NS RYDAF NS.PRA

11
MLPs: Delayed Fuse

2018-07-09 seekingalpha
In a rising broad market and a mixed commodity price backdrop, midstream stocks traded up but lagged the S&P 500 and utilities this week. Recent midstream corporation and utility outperformance has helped the Alerian Energy Infrastructure Index (AMEI) cut into the YTD lead the Alerian MLP Index has maintained since the MLP spike in January.
BKEP TGE PAGP SMLP ENB KEY IPL TEP BPL TEGP CEQP NSH OKE.WI EBBNF OKE BIP MMP IPPLF ENBBF BWP NS.PRC ENB NS.PRB PPL SEMG NS NS.PRA

3
LSC Communications downgraded to underweight from neutral at J.P. Morgan

2018-07-06 marketwatch
Detailed Research: Economic Perspectives on LSC Communications, Cardiovascular, RPX, Nustar Energy, LSB Industries, and Digi International -- What Drives Growth in Today's Competitive Landscape
LKSD NS.PRC NS.PRB NS IO LXU LKSD.WI DGII NS.PRA UMBF

2
NS / NuStar Energy L.P. 8-K (Prospectus)

2018-06-29 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
NS

3
NS / NuStar Energy L.P. 8-K (Prospectus)

2018-06-29 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
NS

2
NS / NuStar Energy L.P. 8-K (Current Report)

2018-06-29 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
NS

3
NS / NuStar Energy L.P. 425 (Prospectus)

2018-06-27 sec.gov
425 Filed by NuStar Energy L.P. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934
NS

2
NS / NuStar Energy L.P. 425 (Prospectus)

2018-06-27 sec.gov
425 Filed by NuStar Energy L.P. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934
NS

2
NS / NuStar Energy L.P. 424B3 (Prospectus)

2018-06-25 sec.gov
424b3 Table of Contents Filed pursuant to Rule 424(b)(3) Registration No. 333-223671 NUSTAR GP HOLDINGS, LLC UNITHO
NS

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

22m - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

1h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

22h - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to NS / NuStar Energy L.P. on message board site Silicon Investor.

Sequans Communications Mainstream Politics and Economics
vitamins herbs supplements longevity and aging Politics for Conservatives
Guns - Americau0027s Greatest Legacy Clown-Free Zone... sorry, no clowns allowed
Anthony @ Equity Investigations, Dear Anthony, Sequans, the investors board
FLYHT Aerospace Solutions Ltd. Questions and Answers with SI Admin (s)
CUSIP: 67058H102